[Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime]
- PMID: 3099518
[Development of a polyvalent erythrocyte diagnostic agent based on the antigens of Pseudomonas aeruginosa slime]
Abstract
The study has revealed the fundamental possibility, and established the concrete conditions of obtaining standard erythrocyte polyvalent diagnosticum for the detection of antibodies to the antigens of P. aeruginosa, belonging to 5 types most frequently occurring in clinical practice, in the passive hemagglutination test. The data on high type- and species-specificity of the new erythrocyte diagnosticum have been obtained, which indicates that slime antigens have been correctly chosen as sensitins and confirms the necessity of using the polyvalent preparation. Preliminary data on the clinical trial of the erythrocyte diagnosticum show the expediency of its use for the control of specific immune response in donors in the process of obtaining anti-P. aeruginosa hyperimmune plasma, as well as the possibility of using this method for the serological diagnosis of P. aeruginosa infection. The diagnostic preparation has been found to retain its activity for 10 months (the term of observation).
Similar articles
-
[Use of a polyvalent erythrocyte diagnostic agent for determining antibodies to Pseudomonas aeruginosa in clinical practice].Zh Mikrobiol Epidemiol Immunobiol. 1989 Jan;(1):46-50. Zh Mikrobiol Epidemiol Immunobiol. 1989. PMID: 2496541 Russian.
-
[Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A].Zh Mikrobiol Epidemiol Immunobiol. 1988 Dec;(12):38-41. Zh Mikrobiol Epidemiol Immunobiol. 1988. PMID: 3149841 Russian.
-
Immunogenic properties of slime produced by Pseudomonas aeruginosa.Arch Immunol Ther Exp (Warsz). 1979;27(4):585-9. Arch Immunol Ther Exp (Warsz). 1979. PMID: 117786
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.Expert Rev Vaccines. 2005 Oct;4(5):645-56. doi: 10.1586/14760584.4.5.645. Expert Rev Vaccines. 2005. PMID: 16221066 Review.